National Healthcare Properties, Inc. quarterly report, Q3 FY2025

Business Context and Reporting Period

Company: National Healthcare Properties, Inc. (NHP)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025
Business Overview: NHP is a non-listed REIT owning a diversified portfolio of healthcare-related real estate, primarily Outpatient Medical Facilities (OMFs) and Senior Housing Operating Properties (SHOPs). As of September 30, 2025, the portfolio consisted of 174 properties across 30 states totaling 7.3 million rentable square feet. The Company completed an "Internalization" in September 2024, transitioning from external management to self-management, eliminating ongoing advisory and property management fees to related parties.

Key Financial Metrics

Metric (Nine Months Ended Sept 30, 2025) Value (in thousands)
Revenue from Tenants $257,801
Net Loss (GAAP) $(34,881)
Net Loss Attributable to Common Stockholders $(45,087)
Funds from Operations (FFO) $16,178
Adjusted Funds from Operations (AFFO) $28,242
Net Cash Used in Operating Activities $(3,008)
Net Cash Provided by Investing Activities $73,137
Net Cash Used in Financing Activities $(41,688)
Total Debt (Gross) $1,042,129
Cash and Cash Equivalents $47,059
Restricted Cash $55,477
Weighted-Average Interest Rate (Total Debt) 5.44%

Material Changes vs. Prior Period

  • Net Loss Improvement: Net loss attributable to common stockholders improved significantly to $(45.1) million for the nine months ended September 30, 2025, compared to $(183.1) million in the same period of 2024. This improvement is primarily driven by the elimination of $106.7 million in termination fees and $19.2 million in operating fees to related parties incurred in 2024 due to the Internalization.
  • Impairment Charges: Impairment charges increased to $33.8 million in 2025 (vs. $11.5 million in 2024), primarily related to writing down five SHOPs and four OMFs to their estimated fair value or contractual sales prices.
  • Asset Dispositions: The Company disposed of 15 OMFs and four SHOPs in the first nine months of 2025 for an aggregate contract sales price of $191.6 million, resulting in a gain on sale of $28.3 million. This compares to dispositions totaling $82.6 million with a $1.4 million gain in the prior year period.
  • Segment Performance:
    • OMF Segment: Net Operating Income (NOI) decreased 17.4% to $60.7 million, driven by property dispositions.
    • SHOP Segment: NOI increased 20.1% to $31.2 million, driven by occupancy gains and lower insurance expenses.

Guidance, Outlook, and Risks

  • Liquidity: Management believes it has sufficient liquidity to meet obligations for the next 12 months. Future liquidity will be funded by cash on hand, operating cash flows, property dispositions, and potential new financings on unencumbered assets ($418.9 million).
  • Debt Maturities: Significant debt maturities are scheduled for 2026, including $334.7 million in Fannie Mae secured debt and $331.1 million in mortgage notes payable.
  • Preferred Stock Repurchases: The Board authorized a $50.0 million repurchase program for Series A and Series B Preferred Stock. During the nine months ended September 30, 2025, the Company repurchased approximately $4.5 million of preferred stock.
  • Risks: Key risks include the impact of high interest rates on refinancing costs, inflationary pressures on operating expenses (particularly labor in SHOPs), and the ability to lease properties on favorable terms. The Company maintains a 100% valuation allowance on deferred tax assets due to the TRS's historical operating losses.
  • Subsequent Events: Post-period, the Company sold one SHOP for $6.3 million and entered into agreements to sell four additional properties for $4.7 million.

Investor Verification Checklist

  • Debt Refinancing: Verify the Company's ability to refinance or repay the $665.9 million in debt maturing in 2026, given current interest rate environments.
  • SHOP Occupancy Trends: Monitor occupancy rates in the SHOP segment to ensure the recent NOI growth is sustainable amidst rising labor costs.
  • Impairment Frequency: Assess the frequency of impairment charges ($33.8 million YTD) to determine if the portfolio valuation is under pressure.
  • Preferred Stock Distributions: Confirm the Company's ability to maintain cumulative distributions on Series A (7.375%) and Series B (7.125%) preferred stock, which are funded by cash on hand rather than operating cash flow.
  • Internalization Savings: Validate that the elimination of related-party fees is resulting in sustained reductions in General and Administrative expenses.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.